Results 141 to 150 of about 971 (198)

Pharmacological inhibition of RAS pathway alleviates spine deformity in a mouse model of neurofibromatosis type 1. [PDF]

Bone Res
Kovaci F, Goachet C, Perrin S, Slimani L, Coulpier F, Tilotta F, Topilko P, Colnot C.   +7 more
europepmc   +1 more source

A Lesson Learned in Managing Traumatic Cervical Neurofibromatosis Type 1. [PDF]

Cureus
Syed Afandi SFS, Ibrahim R, Mohamad Yunus MR.   +2 more
europepmc   +1 more source

Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments. [PDF]

J Neurooncol
Barton B, Wolters PL, Walsh KS, Ullrich NJ, Rosser T, Tonsgard J, Viskochil D, Schorry E, Klesse LJ, Fisher MJ, Gutmann DH, Packer RJ, Korf B, Acosta MT, North KN, Payne JM, NF Clinical Trials Consortium.   +16 more
europepmc   +1 more source

Mapping the Somatic Mutation Landscape of Familial NF2-Related Schwannomatosis using Whole-Exome Sequencing. [PDF]

Int J Med Sci
Luo F, Jiang L, Pan Y, Li H, Tan J, Wu C, Liu Q.   +6 more
europepmc   +1 more source

Cancer Variant Interpretation Group UK (CanVIG-UK): updates on an exemplar national subspecialty multidisciplinary network

Garrett A, Allen S, Rowlands CF, Choi S, Durkie M, Burghel GJ, Robinson R, Callaway A, Field J, Frugtniet B, Palmer-Smith S, Grant J, Pagan J, McDevitt T, Hughes L, Johnston E, Yarram-Smith L, Logan P, Reed L, Snape K, Hanson H, McVeigh T, Turnbull C, CanVIG-UK.   +23 more
europepmc   +1 more source

Ossification of Mandibular Central Giant Cell Granuloma (CGCG) in Neurofibromatosis Type 1 Patients. [PDF]

Cancer Diagn Progn
Friedrich RE, Kohlrusch FK, Hagel C, Gosau M.   +3 more
europepmc   +1 more source